Annual Long Term Debt
$7.92 M
-$2.44 M-23.53%
31 December 2023
Summary:
BioLineRx annual long term debt is currently $7.92 million, with the most recent change of -$2.44 million (-23.53%) on 31 December 2023. During the last 3 years, it has risen by +$6.19 million (+358.75%). BLRX annual long term debt is now -23.53% below its all-time high of $10.36 million, reached on 31 December 2022.BLRX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$19.27 M
-$824.00 K-4.10%
01 September 2024
Summary:
BioLineRx quarterly long term debt is currently $19.27 million, with the most recent change of -$824.00 thousand (-4.10%) on 01 September 2024. Over the past year, it has increased by +$11.36 million (+143.43%). BLRX quarterly long term debt is now -4.10% below its all-time high of $20.10 million, reached on 30 June 2024.BLRX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLRX Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +143.4% |
| 3 y3 years | +358.8% | +1016.7% |
| 5 y5 years | +4.7% | +154.9% |
BLRX Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -23.5% | +358.8% | -4.1% | +1227.5% |
| 5 y | 5 years | -23.5% | +358.8% | -4.1% | +1227.5% |
| alltime | all time | -23.5% | >+9999.0% | -4.1% | >+9999.0% |
BioLineRx Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $19.27 M(-4.1%) |
| June 2024 | - | $20.10 M(+180.4%) |
| Mar 2024 | - | $7.17 M(-9.5%) |
| Dec 2023 | $7.92 M(-23.5%) | $7.92 M(-18.4%) |
| Sept 2023 | - | $9.71 M(-3.7%) |
| June 2023 | - | $10.08 M(+1.4%) |
| Mar 2023 | - | $9.94 M(-4.0%) |
| Dec 2022 | $10.36 M(+499.9%) | $10.36 M(+5.0%) |
| Sept 2022 | - | $9.86 M(+579.1%) |
| June 2022 | - | $1.45 M(-12.4%) |
| Mar 2022 | - | $1.66 M(-3.9%) |
| Dec 2021 | $1.73 M(-60.8%) | $1.73 M(+2.9%) |
| Sept 2021 | - | $1.68 M(-38.0%) |
| June 2021 | - | $2.71 M(-22.4%) |
| Mar 2021 | - | $3.49 M(-20.7%) |
| Dec 2020 | $4.40 M(-41.8%) | $4.40 M(-14.6%) |
| Sept 2020 | - | $5.16 M(-13.5%) |
| June 2020 | - | $5.96 M(-11.3%) |
| Mar 2020 | - | $6.71 M(-11.2%) |
| Dec 2019 | $7.56 M | $7.56 M(+6.9%) |
| Sept 2019 | - | $7.07 M(-7.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $7.68 M(-8.1%) |
| Mar 2019 | - | $8.36 M(+6.6%) |
| Dec 2018 | $7.84 M(+4892.4%) | $7.84 M(+9014.0%) |
| Sept 2018 | - | $86.00 K(-21.1%) |
| June 2018 | - | $109.00 K(-18.0%) |
| Mar 2018 | - | $133.00 K(-15.3%) |
| Dec 2017 | $157.00 K(-37.2%) | $157.00 K(-12.8%) |
| Sept 2017 | - | $180.00 K(-11.3%) |
| June 2017 | - | $203.00 K(-10.6%) |
| Mar 2017 | - | $227.00 K(-9.2%) |
| Dec 2016 | $250.00 K(-27.3%) | $250.00 K(-8.1%) |
| Sept 2016 | - | $272.00 K(-8.1%) |
| June 2016 | - | $296.00 K(-7.5%) |
| Mar 2016 | - | $320.00 K(-7.0%) |
| Dec 2015 | $344.00 K(+1090.3%) | $344.00 K(-6.0%) |
| Sept 2015 | - | $366.00 K(+4780.0%) |
| Mar 2012 | - | $7500.00(-74.0%) |
| Dec 2011 | $28.90 K | $28.90 K(-43.3%) |
| Sept 2011 | - | $51.00 K(-35.8%) |
| June 2011 | - | $79.40 K(-21.0%) |
| Mar 2011 | - | $100.50 K |
FAQ
- What is BioLineRx annual long term debt?
- What is the all time high annual long term debt for BioLineRx?
- What is BioLineRx quarterly long term debt?
- What is the all time high quarterly long term debt for BioLineRx?
- What is BioLineRx quarterly long term debt year-on-year change?
What is BioLineRx annual long term debt?
The current annual long term debt of BLRX is $7.92 M
What is the all time high annual long term debt for BioLineRx?
BioLineRx all-time high annual long term debt is $10.36 M
What is BioLineRx quarterly long term debt?
The current quarterly long term debt of BLRX is $19.27 M
What is the all time high quarterly long term debt for BioLineRx?
BioLineRx all-time high quarterly long term debt is $20.10 M
What is BioLineRx quarterly long term debt year-on-year change?
Over the past year, BLRX quarterly long term debt has changed by +$11.36 M (+143.43%)